Figure 5From: Recombinant Chimeric Antibody hCAb as a Novel Anti-human Colorectal Carcinoma AgentGrowth kinetics of xenograft models. Animals were treated with hCAb or 5-fluorouracil or rituximab or left untreated. Data points represent 6 animals in each group. (A: SW480 xenograft model; B: Hce-8693 xenograft model).*Results were considered significant (P < 0.05, versus untreated control groups).Back to article page